EpsteinAEDiMarcoJPEllenbogenKAet al.ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol2008; 51: e1–62.
2.
ElliottPMAnastasakisAet al.Authors/Task Force members. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J2014; 35: 2733–2779.
3.
MaronBJOlivottoISpiritoPet al.Epidemiology of hypertrophic cardiomyopathy-related death: Revisited in a large non-referral-based patient population. Circulation2000; 102: 858–864.
4.
DunbarSBDoughertyCMSearsSFet al.Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: A scientific statement from the American Heart Association. Circulation2012; 126: 2146–2172.
5.
RumsfeldJSAlexanderKPGoffDCJret al.Cardiovascular health: The importance of measuring patient-reported health status: A scientific statement from the American Heart Association. Circulation2013; 127: 2233–2249.
6.
WongFMFSitJWHWongEMLet al.Factors associated with health-related quality of life among patients with implantable cardioverter defibrillator: Identification of foci for nursing intervention. J Adv Nurs2014; 70: 2821–2834.
7.
ZanggerGZwislerADKikkenborg BergSet al.Psychometric properties of HeartQoL, a core heart disease-specific health-related quality of life questionnaire, in Danish implantable cardioverter defibrillator recipients. Eur J Prev Cardiol2018; 25: 142–149.
8.
OldridgeNHoferSMcGeeHet al.The HeartQoL: Part II. Validation of a new core health-related quality of life questionnaire for patients with ischemic heart disease. Eur J Prev Cardiol2014; 21: 98–106.
9.
De SmedtDClaysEHoferSet al.Validity and reliability of the HeartQoL questionnaire in a large sample of stable coronary patients: The EUROASPIRE IV Study of the European Society of Cardiology. Eur J Prev Cardiol2016; 23: 714–721.
10.
KristensenMSZwislerADBergSKet al.Validating the HeartQoL questionnaire in patients with atrial fibrillation. Eur J Prev Cardiol2016; 23: 1496–1503.
